Want to track NOT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Novartis AG (NOT) Statistics
Valuation metrics
Market Cap -
Enterprise value 23.94B
Trailing P/E (ttm) 17.82
Forward P/E -
PEG ratio -1.81
Price/Sales (ttm) -
Price/Book (mrq) 6.3
Enterprise Value/Revenue 0.42
Enterprise Value/EBITDA 1.04
Overview
Shares outstanding 1.91B
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 30
Average volume (90 days) 15
Price summary
52-Week low 97.45
52-Week high 143.42
Beta -
50-Day moving average 128.95
200-Day moving average 119.39
Dividends and splits
Forward annual dividend rate 16.17
Forward annual dividend yield 0.1259%
Trailing annual dividend rate 4.04
Trailing annual dividend yield 0.0315%
5-Year annual dividend yield -
Payout ratio -
Dividend Date 12 Mar 2026
Ex-Dividend Date 10 Mar 2026
Last split factor 6:5
Last split Date 4 Oct 2023
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.76%
Operating margin 0.31%
Operational effectiveness
Return on assets 0.13%
Return on equity 0.3%
Income Statement
Revenue (ttm) 56.67B
Revenue per share (ttm) 29.23
Quarterly revenue growth (yoy) -0.02%
Gross profit (ttm) 42.98B
EBITDA 22.4B
Net income to common (ttm) 13.98B
Diluted EPS (ttm) 7.15
Quarterly earnings growth (yoy) -0.01%
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) -
Total debt (mrq) 47B
Total Debt/Equity (mrq) 1.21
Current ratio (mrq) 0.85%
Book value per share (mrq) 20.39
Cash Flow
Cash flow statement 21.21B
Levered free cash flow (LFCF) 13.98B
